These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29667823)

  • 21. Application of Bioactivity Profile-Based Fingerprints for Building Machine Learning Models.
    Sturm N; Sun J; Vandriessche Y; Mayr A; Klambauer G; Carlsson L; Engkvist O; Chen H
    J Chem Inf Model; 2019 Mar; 59(3):962-972. PubMed ID: 30408959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of compound administration methods in biochemical assays: effects on apparent compound potency using either assay-ready compound plates or pin tool-delivered compounds.
    Smith T; Ho PI; Yue K; Itkin Z; MacDougall D; Paolucci M; Hill A; Auld DS
    J Biomol Screen; 2013 Jan; 18(1):14-25. PubMed ID: 22904199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery.
    Shi S; Fu L; Yi J; Yang Z; Zhang X; Deng Y; Wang W; Wu C; Zhao W; Hou T; Zeng X; Lyu A; Cao D
    Nucleic Acids Res; 2024 Jul; 52(W1):W439-W449. PubMed ID: 38783035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Luciferase Reporter Gene System for High-Throughput Screening of γ-Globin Gene Activators.
    Xie W; Silvers R; Ouellette M; Wu Z; Lu Q; Li H; Gallagher K; Johnson K; Montoute M
    Methods Mol Biol; 2016; 1439():207-26. PubMed ID: 27316998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrrolo[2,3-b]quinoxalines as inhibitors of firefly luciferase: their Cu-mediated synthesis and evaluation as false positives in a reporter gene assay.
    Nakhi A; Rahman MS; Kishore R; Meda CL; Deora GS; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6433-41. PubMed ID: 22981335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Small-Molecule Frequent Hitters of Glutathione S-Transferase-Glutathione Interaction.
    Brenke JK; Salmina ES; Ringelstetter L; Dornauer S; Kuzikov M; Rothenaigner I; Schorpp K; Giehler F; Gopalakrishnan J; Kieser A; Gul S; Tetko IV; Hadian K
    J Biomol Screen; 2016 Jul; 21(6):596-607. PubMed ID: 27044684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False positives in the early stages of drug discovery.
    Sink R; Gobec S; Pečar S; Zega A
    Curr Med Chem; 2010; 17(34):4231-55. PubMed ID: 20939815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays.
    D'Alessandro S; Camarda G; Corbett Y; Siciliano G; Parapini S; Cevenini L; Michelini E; Roda A; Leroy D; Taramelli D; Alano P
    J Antimicrob Chemother; 2016 May; 71(5):1148-58. PubMed ID: 26888912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
    Jenkins JL; Kao RY; Shapiro R
    Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Throughput Firefly Luciferase Reporter Assays.
    Siebring-van Olst E; van Beusechem VW
    Methods Mol Biol; 2018; 1755():19-29. PubMed ID: 29671260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening to identify potent sepiapterin reductase inhibitors.
    Gao H; Schneider S; Andrews P; Wang K; Huang X; Sparling BA
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126793. PubMed ID: 31740247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target specific compound identification using a support vector machine.
    Plewczynski D; von Grotthuss M; Spieser SA; Rychlewski L; Wyrwicz LS; Ginalski K; Koch U
    Comb Chem High Throughput Screen; 2007 Mar; 10(3):189-96. PubMed ID: 17346118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High-throughput screening of human soluble protein tyrosine phosphatase 1B inhibitors].
    Pang XB; Xie XM; Wang SB; Du GH
    Yao Xue Xue Bao; 2011 Sep; 46(9):1058-64. PubMed ID: 22121775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of a Luminescence-Based High-Throughput Screening Assay for Detecting Apyrase Activity.
    Veloria JR; Devkota AK; Cho EJ; Dalby KN
    SLAS Discov; 2017 Jan; 22(1):94-101. PubMed ID: 27821623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of CYP3A4 inhibition models: comparisons of machine-learning techniques and molecular descriptors.
    Arimoto R; Prasad MA; Gifford EM
    J Biomol Screen; 2005 Apr; 10(3):197-205. PubMed ID: 15809315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.